Don’t Skip Regulatory When Monitoring In Clinical Research

Don't Skip Regulatory When Monitoring In Clinical Research http://www.TheClinicalTrialsGuru.com Site Owner Academy: http://www.theclinicaltrialsguru.com/site-owner-academy/ My CRO: http://www.DSCScro.com My CRA Academy: http://www.TheCRAacademy.com My Research News Site: http://www.TheClinicalScoop.com Call/Text: (949) 415-6256 Follow Me On: SnapChat: username is dansfera Instagram: https://instagram.com/dansfera Twitter: https://twitter.com/TheRealDanSfera Facebook: https://www.facebook.com/dansfera LinkedIn: https://www.linkedin.com/profile/view... My iTunes Podcast: https://itunes.apple.com/us/podcast/random-musings-from-the-clinical-trials-guru/id1245751329 My Stitcher Podcast: http://www.stitcher.com/podcast/dan-s...

Serious CRA’s know that items such as licenses and trainings will expire at different points throughout the study. For this reason it is always important to review the regulatory sections of the ISF. Checking this section is important even if things like the 1572 and delegation of duties have not changed since the last monitoring visit.